January 2027 Options Now Available For Ultragenyx Pharmaceutical (RARE)

The article outlines two options strategies for Ultragenyx Pharmaceutical (RARE), currently trading at $30.21, presenting potential 'YieldBoost' opportunities. For investors willing to acquire RARE, selling a $30.00 strike put for a $5.00 premium effectively lowers the purchase price to $25.00 if assigned, or yields an 11.00% annualized return if the option expires worthless (69% probability). Alternatively, for current shareholders, selling a $35.00 strike covered call for a $6.00 premium could generate a 35.72% total return if the stock is called away, or a 13.11% annualized premium if the option expires worthless (39% probability). The analysis also notes the implied volatilities of these options (61-62%) relative to RARE's 51% trailing 12-month actual volatility.

Analysis

The options market for Ultragenyx Pharmaceutical (RARE) presents two distinct income-generating strategies, underpinned by elevated implied volatility. For investors seeking to initiate a position, selling the $30.00 strike put contract for a $5.00 premium offers a potential entry point at an effective cost basis of $25.00, a notable discount to the current $30.21 share price. This strategy carries a 69% statistical probability of the option expiring worthless, in which case the seller would realize an 11.00% annualized return on the cash commitment. For existing shareholders, a covered call strategy involving the $35.00 strike for a $6.00 premium could generate a 13.11% annualized yield if the option expires out-of-the-money, or a 35.72% total return if the stock is called away by the January 2027 expiration. A key factor in both scenarios is the volatility differential: the options' implied volatility of 61-62% is significantly higher than the stock's 51% trailing twelve-month actual volatility, suggesting that option premiums are currently rich relative to recent historical price action, which generally favors option sellers.

Key Decisions for Investors

• Investors bullish on RARE but seeking a lower entry point could consider selling the $30.00 strike put to either acquire shares at an effective cost basis of $25.00 or generate an 11.00% annualized yield.
• Current RARE shareholders can generate income by selling the $35.00 strike covered call, which provides a 13.11% annualized yield boost but requires accepting a capped total return of 35.72% and the potential sale of shares if the price surpasses the strike.
• The elevated implied volatility of 61-62% versus the 51% historical volatility indicates that option premiums are currently high, suggesting that now may be an opportune time to implement option-selling strategies on RARE, while also acknowledging the market's expectation for increased price swings.